A multi-millionaire co-founder of an Australian video technology firm, whose innovations have powered some of Hollywood's biggest cinematic spectacles, has told the Federal Court he has been unfairly prevented from selling his significant stake in the billion-dollar enterprise, citing a decade of alleged hostility from fellow shareholders.

Dr. Jonathan Heng, a co-founder of the Melbourne-based company Blackmagic Design, is locked in a high-stakes legal dispute with fellow directors and shareholders, including fellow founders Grant Petty and Douglas Clarke, over his inability to liquidate his substantial shareholding. The court heard claims that their alleged actions have effectively trapped Dr. Heng's investment, which he estimates is worth hundreds of millions of dollars, within the privately held company.

Blackmagic Design, established in 2001, has grown into a global powerhouse, providing high-end video capture cards, cameras, and software used in major film productions, including Marvel blockbusters and hit television series. Its success has cemented its founders' positions among Australia's wealthiest individuals, with the company's valuation reportedly soaring into the billions of Australian dollars.

Allegations of a 'Concerted Campaign'

According to ABC News NSW, legal documents filed with the Federal Court allege that Grant Petty and Douglas Clarke, along with other shareholders, have engaged in a deliberate and sustained campaign to hinder Dr. Heng from selling his shares. This alleged campaign reportedly includes rejecting potential buyers and refusing to facilitate the sale to third parties, despite Dr. Heng's desire to diversify his investments and extract value from his long-term holding.

Dr. Heng's legal team contends that the company's constitution, which grants existing shareholders pre-emptive rights to purchase shares, has been manipulated to his detriment. It is argued that while the constitution aims to maintain shareholder control, it has been used as a tool to unfairly restrict Dr. Heng's financial liquidity and return on investment. The case hinges on whether the actions of the other shareholders constitute an oppressive or unfair conduct under Australian corporations law.

The Roots of Discord

The deepening rift between the co-founders reportedly stems back a decade, evolving into a period of pronounced antagonism that Dr. Heng claims has made his position within the company untenable. While the specific incidents triggering this breakdown in relations were not fully detailed in initial reports, the court proceedings are expected to uncover the history of animosity that has led to this dramatic legal confrontation.

The commercial implications for Blackmagic Design, a company lauded for its contribution to Australia's tech and creative industries, could be significant. Public awareness of such internal disputes can impact investor confidence and company morale, even for a privately owned entity of this stature. The company's innovative products are ubiquitous in post-production studios worldwide, from Hollywood to Pinewood, making this case of keen interest to the global film and television industry.

Billions at Stake

At the heart of the dispute is the immense value of Dr. Heng's shareholding. While an exact figure has not been publicly disclosed, a company valued in the billions suggests Dr. Heng's stake would be worth a very substantial sum, potentially hundreds of millions of Australian dollars. His inability to sell these shares means a significant portion of his wealth remains illiquid, tied up in a company where he alleges he faces opposition.

The case highlights the complex challenges that can arise in privately held, high-growth companies, particularly when founding relationships sour. While venture capital funds and other investors typically have clear exit strategies, co-founders often rely on internal agreements that can become contentious when personal or financial priorities diverge. The Federal Court will now be tasked with unravelling these intricate dynamics and determining whether Dr. Heng's claims of being unfairly barred from exiting his investment hold merit under Australian law.